La colangite autoimmune (CBP AMA negativa)

Translated title of the contribution: Autoimmune cholangitis (AMA-negative PBC)

Pietro Invernizzi

Research output: Contribution to journalArticle

Abstract

"Autoimmune cholangitis" is a term recently proposed to describe patients with clinical, biochemical, and histological features of primary biliary cirrhosis but lacking antimitochondrial antibodies, a serologie marker present in about 90% of patients with primary biliary cirrhosis. Although patients with "autoimmune cholangitis" have several peculiar serologie immunoreactivities and an anomalous expression of mitochondrial autoantigens at liver level, they seem not to differ from patients with antimitochondrial antibodies-positive primary biliary cirrhosis with respect to relevant biochemical, histological and clinicotherapeutic features. In this article we discuss in detail data supporting and data contrasting a new classification of chronic cholestatic liver diseases which include "autoimmune cholangitis" as a new clinical entity distinct from primary biliary cirrhosis.

Original languageItalian
Pages (from-to)141-147
Number of pages7
JournalArgomenti di Gastroenterologia Clinica
Volume11
Issue number4
Publication statusPublished - Aug 1998

Fingerprint

Cholangitis
Biliary Liver Cirrhosis
Antibodies
Autoantigens
Liver Diseases
Liver

ASJC Scopus subject areas

  • Gastroenterology

Cite this

La colangite autoimmune (CBP AMA negativa). / Invernizzi, Pietro.

In: Argomenti di Gastroenterologia Clinica, Vol. 11, No. 4, 08.1998, p. 141-147.

Research output: Contribution to journalArticle

Invernizzi, P 1998, 'La colangite autoimmune (CBP AMA negativa)', Argomenti di Gastroenterologia Clinica, vol. 11, no. 4, pp. 141-147.
Invernizzi, Pietro. / La colangite autoimmune (CBP AMA negativa). In: Argomenti di Gastroenterologia Clinica. 1998 ; Vol. 11, No. 4. pp. 141-147.
@article{2bfbf03cffd1409b8b4cdc8a9d34ef05,
title = "La colangite autoimmune (CBP AMA negativa)",
abstract = "{"}Autoimmune cholangitis{"} is a term recently proposed to describe patients with clinical, biochemical, and histological features of primary biliary cirrhosis but lacking antimitochondrial antibodies, a serologie marker present in about 90{\%} of patients with primary biliary cirrhosis. Although patients with {"}autoimmune cholangitis{"} have several peculiar serologie immunoreactivities and an anomalous expression of mitochondrial autoantigens at liver level, they seem not to differ from patients with antimitochondrial antibodies-positive primary biliary cirrhosis with respect to relevant biochemical, histological and clinicotherapeutic features. In this article we discuss in detail data supporting and data contrasting a new classification of chronic cholestatic liver diseases which include {"}autoimmune cholangitis{"} as a new clinical entity distinct from primary biliary cirrhosis.",
author = "Pietro Invernizzi",
year = "1998",
month = "8",
language = "Italian",
volume = "11",
pages = "141--147",
journal = "Argomenti di Gastroenterologia Clinica",
issn = "1120-8651",
publisher = "Masson SpA",
number = "4",

}

TY - JOUR

T1 - La colangite autoimmune (CBP AMA negativa)

AU - Invernizzi, Pietro

PY - 1998/8

Y1 - 1998/8

N2 - "Autoimmune cholangitis" is a term recently proposed to describe patients with clinical, biochemical, and histological features of primary biliary cirrhosis but lacking antimitochondrial antibodies, a serologie marker present in about 90% of patients with primary biliary cirrhosis. Although patients with "autoimmune cholangitis" have several peculiar serologie immunoreactivities and an anomalous expression of mitochondrial autoantigens at liver level, they seem not to differ from patients with antimitochondrial antibodies-positive primary biliary cirrhosis with respect to relevant biochemical, histological and clinicotherapeutic features. In this article we discuss in detail data supporting and data contrasting a new classification of chronic cholestatic liver diseases which include "autoimmune cholangitis" as a new clinical entity distinct from primary biliary cirrhosis.

AB - "Autoimmune cholangitis" is a term recently proposed to describe patients with clinical, biochemical, and histological features of primary biliary cirrhosis but lacking antimitochondrial antibodies, a serologie marker present in about 90% of patients with primary biliary cirrhosis. Although patients with "autoimmune cholangitis" have several peculiar serologie immunoreactivities and an anomalous expression of mitochondrial autoantigens at liver level, they seem not to differ from patients with antimitochondrial antibodies-positive primary biliary cirrhosis with respect to relevant biochemical, histological and clinicotherapeutic features. In this article we discuss in detail data supporting and data contrasting a new classification of chronic cholestatic liver diseases which include "autoimmune cholangitis" as a new clinical entity distinct from primary biliary cirrhosis.

UR - http://www.scopus.com/inward/record.url?scp=77950423399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950423399&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:77950423399

VL - 11

SP - 141

EP - 147

JO - Argomenti di Gastroenterologia Clinica

JF - Argomenti di Gastroenterologia Clinica

SN - 1120-8651

IS - 4

ER -